Parkinson disease: Intestinal levodopa infusion in PD--the first randomized trial.

This publication has 10 references indexed in Scilit:

• Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
  The Lancet Neurology, 2014
• Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits
  The Lancet Neurology, 2013
• Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery
  Parkinsonism & Related Disorders, 2013
• Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
  Parkinsonism & Related Disorders, 2013
• Complications and Mortality After Percutaneous Endoscopic Gastrostomy in Geriatrics: A Prospective Multicenter Observational Trial
  Journal of the American Medical Directors Association, 2012
• The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
  Movement Disorders, 2011
• Risk Factors and Complications Following Percutaneous Endoscopic Gastrostomy: A Case Series of 1041 Patients
  Canadian Journal of Gastroenterology and Hepatology, 2011
• Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease
  Annals of Neurology, 2010
• Pharmacokinetics and pharmacodynamics of levodopa
  Movement Disorders, 2008
• Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
  The Lancet Neurology, 2006